The 80th American Diabetes
Association(ADA)Scientific Sessions was held online from June 12 to 16, 2020. There was some hot debates on the topics of
diabetes related complications in the annual meeting of ADA.
Endocrinologists and
cardiologists debated and presented different perspectives. This
paper will summarize the debates on the following five topics (1)Microvascular and macrovascular
complications of diabetes are distinct pathophysiologic entities.(2)
Guideline recommendations for
cardiovascular risk and
disease management in
type 2 diabetes.(3)Drawing the line between primary and
secondary prevention—necessary or too simplistic? (4)Should
metformin be considered first-line
therapy for individuals with
type 2 diabetes with established arteriosclerotic
cardiovascular disease(ASCVD)or at high
risk for ASCVD? (5)Primary cardiovascular prevention with
sodium-
glucose co-transporter 2(SGLT2)inhibitors or
glucagon-like peptide-1(
GLP-1)receptor
agonists.